Method for the production of insulin-like growth factor-I

Details for Australian Patent Application No. 2007291501 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Schaubmar, Andreas; Knoetgen, Hendrik; Fischer, Stephan; Hesse, Friederike; Lang, Kurt; Schantz, Christian; Regula, Joerg Thomas

Agent Spruson & Ferguson

Pub. Number AU-B-2007291501

PCT Pub. Number WO2008/025527

Priority 06018171.6 31.08.06 EP

Filing date 29 August 2007

Wipo publication date 6 March 2008

Acceptance publication date 12 July 2012

International Classifications

C07K 14/65 Peptides having more than 20 amino acids

C12N 15/12 Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C12N 9/52 Enzymes, e.g. ligases (6.) - derived from bacteria

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/025527 Priority application(s): WO2008/025527

12 July 2012 Application Accepted

  Published as AU-B-2007291501

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007291502-Method for the production of conjugates of insulin-like growth factor-I and poly(ethylene glycol)

2007291497-Shine-through hydrogen lamp